Stocks Health care RZLT
NASDAQ · Health careRezolute, Inc. (RZLT)
It posted a net loss of $77.6M. At June 30, 2026 it held $10.6M in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on September 24, 2026.
What Rezolute, Inc. does
Rezolute, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker RZLT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | n/a | -$77.6M | -$0.75 | n/a |
| 2025 | n/a | -$74.4M | -$0.98 | n/a |
| 2024 | n/a | -$68.5M | -$1.33 | n/a |
| 2023 | n/a | -$51.8M | -$1.01 | -$44.6M |
| 2022 | n/a | -$41.1M | -$2.32 | n/a |
| 2021 | n/a | -$20.9M | -$2.72 | n/a |
Latest SEC filings
What Rezolute, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 24, 2026Annual report 10-K · period to June 30, 2026
- September 24, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Passive stake (5% or more) SCHEDULE 13G
- June 2, 2026
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 12, 2026Quarterly report 10-Q · period to March 31, 2026
- May 12, 2026
- May 11, 2026Passive stake changed SCHEDULE 13G/A
Questions about RZLT
What does Rezolute, Inc. do?
Rezolute, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker RZLT.
Is Rezolute, Inc. profitable?
No. In fiscal 2026 it reported a net loss of $77.6M.
When did Rezolute, Inc. last report?
Its most recent periodic report is the annual report (10-K) filed on September 24, 2026. It covers the period to June 30, 2026.
Similar companies
Follow RZLT
Get an email when Rezolute, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow RZLT: get an email when it filesWhere the numbers come from
Financial figures are the values Rezolute, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.